The Continuation of Erlotinib

Clinical trial NCT01130779 · UNKNOWN

Trial details

NCT number: NCT01130779
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2009-08-01
Primary completion: 2010-08-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.